A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Palbociclib Impurity 36 | Palbociclib Impurity 36. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: tert-butyl 4-(2-aminopyridin-3-yl)piperazine-1-carboxylate. CAS No. 1023594-49-1. Molecular formula: C14H22N4O2. Mole weight: 278.35. Catalog: APB1023594491. |  |
| Palbociclib Impurity 37 | Palbociclib Impurity 37 is an impurity of Palbociclib, a medication for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. CAS No. 2144748-14-9. Molecular formula: C14H18N6. Mole weight: 270.34. |  |
| Palbociclib Impurity 38 | Palbociclib Impurity 38 is an impurity of Palbociclib, a medication for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Synonyms: 6-(1-Butoxyethenyl)-8-cyclopentyl-5-methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]-pyrido[2,3-d]pyrimidin-7(8H)-one. CAS No. 2270982-31-3. Molecular formula: C28H37N7O2. Mole weight: 503.65. | |
| Palbociclib Impurity 4 | An impurity of Palbociclib which is a selective cyclin-dependent kinase (CDK) 4/6 inhibitor to treat ER-positive and HER2-negative breast cancer. Synonyms: Pyrido[2,?3-d]?pyrimidin-7(8H)?-one, 8-cyclopentyl-6-(1-hydroxyethyl)?-5-methyl-2-[[5-(1-piperazinyl)?-2-pyridinyl]?amino]?-. Grades: > 95%. CAS No. 1376615-91-6. Molecular formula: C24H31N7O2. Mole weight: 449.56. | |
| Palbociclib Impurity 40 | Palbociclib Impurity 40 is an impurity of Palbociclib, a medication for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Molecular formula: C25H35N3O. Mole weight: 393.58. | |
| Palbociclib Impurity 41 | Palbociclib Impurity 41 is an impurity of Palbociclib, a medication for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Molecular formula: C19H24BrN3O. Mole weight: 390.33. | |
| Palbociclib Impurity 42 | Palbociclib Impurity 42 is an impurity of Palbociclib, a medication for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Synonyms: 6-Bromo-2-chloro-8-cyclopentyl-5-methylpyrido-[2,3-d]pyrimidin-7(8H)-one. Grades: 98%. CAS No. 1016636-76-2. Molecular formula: C13H13BrClN3O. Mole weight: 342.62. | |
| Palbociclib Impurity 46 | Palbociclib Impurity 46 is an impurity of Palbociclib, a medication for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Synonyms: 8-Cyclopentyl-5-methylpyrido[2,3-d]pyrimidine-2,7(1H,8H)-dione. CAS No. 2375089-01-1. Molecular formula: C13H15N3O2. Mole weight: 245.28. | |
| Palbociclib Impurity 47 | Palbociclib Impurity 47 is an impurity of Palbociclib, a medication for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Synonyms: 5-Bromo-2-chloropyrimidin-4(3H)-one; 5-Bromo-2-chloro-4(3H)-pyrimidinone; 5-Bromo-2-chloropyrimidin-4-ol. Grades: 95%. CAS No. 844843-37-4. Molecular formula: C4H2BrClN2O. Mole weight: 209.43. | |
| Palbociclib Impurity 48 | Palbociclib Impurity 48 is an impurity of Palbociclib, a medication for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Molecular formula: C40H42Br2N12O2. Mole weight: 882.67. | |
| Palbociclib Impurity 49 | Palbociclib Impurity 49 is an impurity of Palbociclib, a medication for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Synonyms: 4-[6-[(6-Acetyl-8-cyclopentyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridinyl]-γ-oxo-1-piperazinebutanoic acid. CAS No. 1974279-21-4. Molecular formula: C28H33N7O5. Mole weight: 547.62. | |
| Palbociclib Impurity 5 | An impurity of Palbociclib which is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Synonyms: 2-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)-5-(piperazin-1-yl)pyridine 1-oxide. Grades: > 95%. Molecular formula: C24H30N7O3. Mole weight: 464.55. | |
| Palbociclib Impurity 50 | Palbociclib Impurity 50 is an impurity of Palbociclib, a medication for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Molecular formula: C25H29N7O4. Mole weight: 491.55. | |
| Palbociclib Impurity 51 | Palbociclib Impurity 51 is an impurity of Palbociclib, a medication for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Synonyms: 6-acetyl-2-((5-(4-butylpiperazin-1-yl)pyridin-2-yl)amino)-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one. Molecular formula: C28H37N7O2. Mole weight: 503.65. | |
| Palbociclib Impurity 53 | Palbociclib Impurity 53 is an impurity of Palbociclib, a medication for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Synonyms: 5-bromo-2-chloro-N-cyclopentyl-4-pyrimidinamine; 5-bromo-2-chloro-N-cyclopentylpyrimidin-4-amine. Grades: >95%. CAS No. 733039-20-8. Molecular formula: C9H11BrClN3. Mole weight: 276.56. | |
| Palbociclib Impurity 54 | Palbociclib Impurity 54 is an impurity of Palbociclib, a medication for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Synonyms: 2-Chloro-N-cyclopentyl-4-pyrimidinamine; (2-Chloropyrimidin-4-yl)(cyclopentyl)amine. CAS No. 868591-58-6. Molecular formula: C9H12ClN3. Mole weight: 197.67. | |
| Palbociclib Impurity 55 | Palbociclib Impurity 55 is an impurity of Palbociclib, a medication for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Synonyms: 5-Bromo-N,N-dicyclopentyl-2,4-pyrimidinediamine. CAS No. 2444702-87-6. Molecular formula: C14H21BrN4. Mole weight: 325.25. | |
| Palbociclib Impurity 56 | Palbociclib Impurity 56 is an impurity of Palbociclib, a medication for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Synonyms: 6-acetyl-2-((5-(4-acetylpiperazin-1-yl)pyridin-2-yl)amino)-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one. CAS No. 1974279-20-3. Molecular formula: C26H31N7O3. Mole weight: 489.58. | |
| Palbociclib Impurity 57 | Palbociclib Impurity 57 is an impurity of Palbociclib, a medication for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Molecular formula: C24H27N7O3. Mole weight: 461.53. | |
| Palbociclib Impurity 58 | Palbociclib Impurity 58 is an impurity of Palbociclib, a medication for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Synonyms: 6-acetyl-2-((5-aminopyridin-2-yl)amino)-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one. CAS No. 2363172-64-7. Molecular formula: C20H22N6O2. Mole weight: 378.44. | |
| Palbociclib Impurity 59 | Palbociclib Impurity 59 is an impurity of Palbociclib, a medication for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Molecular formula: C24H25N7O4. Mole weight: 475.51. | |
| Palbociclib Impurity 6 | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. Synonyms: 1-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine 1-oxide. Grades: > 95%. Molecular formula: C24H29N7O3. Mole weight: 463.54. | |
| Palbociclib Impurity 6 | Palbociclib Impurity 6. Uses: For analytical and research use. Group: Impurity standards. CAS No. 153747-97-8. Molecular formula: C14H20BrN3O2. Mole weight: 342.23. Catalog: APB153747978. | |
| Palbociclib Impurity 62 | Palbociclib Impurity 62 is an impurity of Palbociclib, a medication for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Molecular formula: C30H35N7O8. Mole weight: 621.65. | |
| Palbociclib Impurity 63 | Palbociclib Impurity 63 is an impurity of Palbociclib, a medication for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Synonyms: 2-Chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one; 2-Chloro-8-cyclopentyl-5-methyl-8H-pyrido[2,3-d]pyrimidin-7-one. Grades: 97%. CAS No. 1013916-37-4. Molecular formula: C13H14ClN3O. Mole weight: 263.73. | |
| Palbociclib Impurity 64 | Palbociclib Impurity 64 is an impurity of Palbociclib, a medication for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Molecular formula: C25H31N7O3. Mole weight: 477.57. | |
| Palbociclib Impurity 65 | Palbociclib Impurity 65 is an impurity of Palbociclib, a medication for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Molecular formula: C24H29N7O3. Mole weight: 463.54. | |
| Palbociclib Impurity 66 | Palbociclib Impurity 66 is an impurity of Palbociclib, a medication for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Molecular formula: C30H35N7O8. Mole weight: 621.65. | |
| Palbociclib Impurity 67 | Palbociclib Impurity 67 is an impurity of Palbociclib, a medication for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. CAS No. 2242625-36-9. Molecular formula: C13H16ClN3O2. Mole weight: 281.74. | |
| Palbociclib Impurity 69 | Palbociclib Impurity 69 is an impurity of Palbociclib, a medication for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. CAS No. 1023594-50-4. Molecular formula: C14H22N4O2. Mole weight: 278.36. | |
| Palbociclib Impurity 7 | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer used in combination with letrozole (an aromatase inhibitor). Synonyms: 1-Piperazinecarboxylic acid, 4-[6-[[6-[(1E)?-2-butoxyethenyl]?-8-cyclopentyl-7,?8-dihydro-5-methyl-7-oxopyrido[2,?3-d]?pyrimidin-2-yl]?amino]?-3-pyridinyl]?-, 1,?1-dimethylethyl ester. Grades: > 95%. CAS No. 827022-35-5. Molecular formula: C33H45N7O4. Mole weight: 603.77. | |
| Palbociclib Impurity 70 | Palbociclib Impurity 70 is an impurity of Palbociclib, a medication for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Molecular formula: C14H22N4O3. Mole weight: 294.36. | |
| Palbociclib Impurity 71 | Palbociclib Impurity 71 is an impurity of Palbociclib, a medication for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Molecular formula: C28H33N7O7. Mole weight: 579.61. | |
| Palbociclib Impurity 74 | Palbociclib Impurity 74 is an impurity of Palbociclib, a medication for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Synonyms: Di-tert-butyl 4,4'-(diazene-1,2-diylbis(pyridine-6,3-diyl))(E)-bis(piperazine-1-carboxylate). CAS No. 2399424-46-3. Molecular formula: C28H40N8O4. Mole weight: 552.68. | |
| Palbociclib Impurity 75 | Palbociclib Impurity 75 is an impurity of Palbociclib, a medication for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Molecular formula: C28H42N8O4. Mole weight: 554.7. | |
| Palbociclib Impurity 75 | Palbociclib Impurity 75. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 2,6-dibromo-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one. CAS No. 1415560-29-0. Molecular formula: C13H13Br2N3O. Mole weight: 387.07. Catalog: APB1415560290. | |
| Palbociclib Impurity 77 | Palbociclib Impurity 77 is an impurity of Palbociclib, a medication for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Molecular formula: C13H12BrCl2N3O. Mole weight: 377.06. | |
| Palbociclib Impurity 78 | Palbociclib Impurity 78 is an impurity of Palbociclib, a medication for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Molecular formula: C14H21N5O4. Mole weight: 323.35. | |
| Palbociclib Impurity 8 | An impurity of Palbociclib which which is a selective cyclin-dependent kinase (CDK) 4/6 inhibitor to treat ER-positive and HER2-negative breast cancer. Synonyms: 1-Piperazinecarboxylic acid, 4-[6-[[8-cyclopentyl-6-(2-ethoxyethenyl)?-7,?8-dihydro-5-methyl-7-oxopyrido[2,?3-d]?pyrimidin-2-yl]?amino]?-3-pyridinyl]?-, 1,?1-dimethylethyl ester. Grades: > 95%. CAS No. 827022-31-1. Molecular formula: C31H41N7O4. Mole weight: 575.72. | |
| Palbociclib Impurity 80 | Palbociclib Impurity 80 is an impurity of Palbociclib, a medication for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Synonyms: 6-acetyl-8-cyclohexyl-5-methyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}-7H,8H-pyrido[2,3-d]pyrimidin-7-one. CAS No. 2624141-94-0. Molecular formula: C25H31N7O2. Mole weight: 461.57. | |
| Palbociclib Impurity 81 | Palbociclib Impurity 81 is an impurity of Palbociclib, a medication for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Synonyms: 5-(piperazin-1-yl)pyridin-2-amine. CAS No. 1082876-26-3. Molecular formula: C9H14N4. Mole weight: 178.24. | |
| Palbociclib Impurity 83 | Palbociclib Impurity 83 is an impurity of Palbociclib, a medication for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Molecular formula: C24H29N7O3. Mole weight: 463.54. | |
| Palbociclib Impurity 84 | Palbociclib Impurity 84 is an impurity of Palbociclib, a medication for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Synonyms: 3-(2-chloro-4-(cyclopentylamino)pyrimidin-5-yl)prop-2-yn-1-ol. CAS No. 1374639-76-5. Molecular formula: C12H14ClN3O. Mole weight: 251.71. | |
| Palbociclib Impurity 9 | An impurity of Palbociclib which is a selective cyclin-dependent kinase (CDK) 4/6 inhibitor to treat ER-positive and HER2-negative breast cancer. Synonyms: 2-(8-cyclopentyl-5-methyl-7-oxo-2-((4-(piperazin-1-yl)phenyl)amino)-7,8-dihydropyrido[2,3-d]pyrimidin-6-yl)acetaldehyde. Grades: > 95%. Molecular formula: C24H29N7O2. Mole weight: 447.54. | |
| Palbociclib Impurity 9 DiHCl | Palbociclib Impurity 9 DiHCl is an impurity of Palbociclib, a medication for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Synonyms: 2-(8-cyclopentyl-5-methyl-7-oxo-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-7,8-dihydropyrido[2,3-d]pyrimidin-6-yl)acetaldehyde, hydrochloride (1:2). Molecular formula: C24H31N7O2Cl2. Mole weight: 520.46. | |
| Palbociclib Impurity F | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. Grades: 95%. CAS No. 1023594-49-1. Molecular formula: C14H22N4O2. Mole weight: 278.35. | |
| Palbociclib Impurity FLT | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. Grades: ≥95%. Molecular formula: C37H51N7O11. Mole weight: 769.85. | |
| Palbociclib Impurity I | Palbociclib Impurity I. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1016636-76-2. Molecular formula: C13H13BrClN3O. Mole weight: 342.62. Catalog: APB1016636762. | |
| Palbociclib Impurity N | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. Grades: ≥95%. Molecular formula: C27H35N7O2. Mole weight: 489.62. | |
| Palbociclib Impurity O | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. Grades: ≥95%. Molecular formula: C28H37N7O2. Mole weight: 503.65. | |
| Palbociclib Impurity P | Palbociclib Impurity P. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1082876-26-3. Molecular formula: C9H14N4. Mole weight: 178.24. Catalog: APB1082876263. | |
| Palbociclib Impurity P | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. Grades: ≥95%. Molecular formula: C41H54BrN11O5. Mole weight: 860.86. | |
| Palbociclib Impurity V | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. Grades: ≥95%. Molecular formula: C28H40N8O5. Mole weight: 568.68. | |
| Palbociclib isethionate | Palbociclib (PD 0332991) isethionate is an orally active selective CDK4 and CDK6 inhibitor with IC 50 values of 11 and 16 nM, respectively. Palbociclib isethionate has potent anti-proliferative activity and induces cell cycle arrest in cancer cells, which can be used in the research of HR-positive and HER2-negative breast cancer and hepatocellular carcinoma [1] [3] [4]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: PD 0332991 isethionate. CAS No. 827022-33-3. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg; 200 mg; 500 mg. Product ID: HY-A0065. |  |
| Palbociclib Isethionate | Palbociclib is a potent Cdk4/6 inhibitor. Synonyms: PD 0332991 Isethionate; PD0332991 Isethionate; PD-0332991 Isethionate; 6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7-one isethionate. Grades: >98%. CAS No. 827022-33-3. Molecular formula: C26H35N7O6S. Mole weight: 573.66. | |
| Palbociclib Isethionate | Palbociclib (PD 0332991) isethionate is an orally active selective CDK4 and CDK6 inhibitor with IC50 values of 11 and 16 nM, respectively. Palbociclib isethionate has potent anti-proliferative activity and induces cell cycle arrest in cancer cells, which can be used in the research of HR-positive and HER2-negative breast cancer and hepatocellular carcinoma. Uses: Designed for use in research and industrial production. Additional or Alternative Names: Palbociclib Isethionate;827022-33-3;PD0332991 Isethionate;PD 0332991 isethionate;UNII-W1NYL2IRDR;Palbociclib (PD0332991) Isethionate;W1NYL2IRDR;Palbociclib (isethionate);827022-33-3 (isethionate);6-acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one 2-hydroxyethanesulfonate;Palbociclib Isethionate [USAN];PD 0332991-0054;PF-00080665-73;6-acetyl-8-. Product Category: Inhibitors. CAS No. 827022-33-3. Molecular formula: C26H35N7O6S. Mole weight: 573.7g/mol. Purity: 0.9999. IUPACName: 6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7-one;2-hydroxyethanesulfonic acid. Canonical SMILES: CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C.C(CS(=O)(=O)O)O. Product ID: ACM827022333. Alfa Chemistry ISO 9001:2015 Certified. |  |
| Palbociclib Lactose adduct 1 | Palbociclib Lactose adduct 1 is an impurity of Palbociclib, a medication for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Synonyms: Palbociclib N-Lactose. Molecular formula: C36H49N7O12. Mole weight: 771.83. | |
| Palbociclib Lactose adduct 2 | Palbociclib Lactose adduct 2 is an impurity of Palbociclib, a medication for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Synonyms: 6-Acetyl-8-cyclopentyl-5-methyl-2-((5-(4-((3S,4R,5R)-3,5,6-trihydroxy-2-oxo-4-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexyl)piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one; Palbociclib Rearranged Lactose Adduct. Molecular formula: C36H49N7O12. Mole weight: 771.83. | |
| Palbociclib monohydrochloride | Palbociclib (PD 0332991) monohydrochloride is an orally active selective CDK4 and CDK6 inhibitor with IC50 values of 11 and 16 nM, respectively. Palbociclib monohydrochloride has potent anti-proliferative activity and induces cell cycle arrest in cancer cells, which can be used in the research of HR-positive and HER2-negative breast cancer and hepatocellular carcinoma[1][3][4]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: PD 0332991 monohydrochloride. CAS No. 827022-32-2. Pack Sizes: 5 mg; 10 mg; 50 mg; 100 mg; 200 mg; 500 mg. Product ID: HY-50767A. | |
| Palbociclib N-b-D-Glucuronide Sodium Salt | Palbociclib N-b-D-Glucuronide Sodium Salt is an impurity of Palbociclib, a medication for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Molecular formula: C30H36N7NaO8. Mole weight: 645.64. | |
| Palbociclib N-Ethyl | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. Synonyms: 6-acetyl-8-cyclopentyl-2-((5-(4-ethylpiperazin-1-yl)pyridin-2-yl)amino)-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one; Palbociclib impurity 33. Grades: ≥95%. CAS No. 1974279-40-7. Molecular formula: C26H33N7O2. Mole weight: 475.59. | |
| Palbociclib N-Glucuronide | A salt of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. Synonyms: (2R,4R,6S)-6-(4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazin-1-yl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid. Grades: > 95%. Molecular formula: C30H37N7O8. Mole weight: 623.66. | |
| Palbociclib N-oxide | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. Synonyms: 1-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine 1-oxide. Grades: ≥95%. CAS No. 2174002-29-8. Molecular formula: C24H29N7O3. Mole weight: 463.53. | |
| Palbociclib Pyridine N-Oxide | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. CAS No. 2098673-40-4. Molecular formula: C24H29N7O3. Mole weight: 463.54. | |
| Palbociclib (Standard) | Palbociclib (Standard) is the analytical standard of Palbociclib. This product is intended for research and analytical applications. Palbociclib (PD 0332991) is an orally active selective CDK4 and CDK6 inhibitor with IC50 values of 11 and 16 nM, respectively. Palbociclib has potent anti-proliferative activity and induces cell cycle arrest in cancer cells, which can be used in the research of HR-positive and HER2-negative breast cancer and hepatocellular carcinoma[1][3][4]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: PD 0332991 (Standard). CAS No. 571190-30-2. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-50767R. | |
| Palbociclib Sulfamic Acid | Palbociclib Sulfamic Acid is an impurity of Palbociclib, a medication for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Synonyms: 4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-sulfonic acid. Grades: > 95%. CAS No. 2204863-10-3. Molecular formula: C24H29N7O5S. Mole weight: 527.61. | |
| PALDA | PALDA. Group: Biochemicals. Grades: Purified. CAS No. 136181-87-8. Pack Sizes: 10mg. US Biological Life Sciences. |  Worldwide |
| PALDA | PALDA is an endogenous lipid and it can potentiate effects of endovanilloids at TRPV1 receptors. Synonyms: N-[2-(3,4-Dihydroxyphenyl)ethyl]hexadecanamide. Grades: ≥98% by HPLC. CAS No. 136181-87-8. Molecular formula: C24H41NO3. Mole weight: 391.59. | |
| Paldimycin | It is produced by the strain of Str. paulus 273. It has anti-gram-positive bacterial effect, but also has weak anti-gram-negative bacterial effect. Paldimycin A has stronger antibacterial activity than Paldimycin B. Synonyms: Antibiotic 273 A1; (5S) -5- [5- [3- [ (2R) -2-acetamido-2-carboxyethyl] sulfanyl-2- [ [ (2R) -2-acetamido-2-carboxyethyl] sulfanylcarbothioylamino] butanoyl] oxy-6- (acetyloxymethyl) -3-hydroxy-4- [5-hydroxy-4-methoxy-6-methyl-5- [ (1S) -1- (2-methylpropanoyloxy) ethyl] oxan-2-yl] oxyoxan-2-yl] -2-amino-5-hydroxy-3, 6-dioxocyclohexene-1-carboxylic acid; (5S) -5- [5- [3- [ (2R) -2-acetamido-2-carboxyethyl] sulfanyl-2- [ [ (2R) -2-acetamido-2-carboxyethyl] sulfanylcarbothioylamino] butanoyl] oxy-6- (acetyloxymethyl) -3-hydroxy-4- [5-hydroxy-4-methoxy-6-methyl-5- [ (1S) -1- [ (2S) -2-methylbutanoyl] oxyethyl] oxan-2-yl] oxyoxan-2-yl] -2-amino-5-hydroxy-3, 6-dioxocyclohexene-1-carboxylic acid. CAS No. 102426-96-0. Molecular formula: C87H126N8O46S6. Mole weight: 2212.34. | |
| Paldimycin A | It is produced by the strain of Str. paulus 273. It has anti-gram-positive bacterial effect, but also has weak anti-gram-negative bacterial effect. Paldimycin A has stronger antibacterial activity than Paldimycin B. Synonyms: Antibiotic 273 A1-alpha; L-Cysteine, N-acetyl-, [2-[[2- (acetylamino)-2-carboxyethyl]thio]-1-carboxypropyl]carbamodithioate (ester), 4'-ester with 5-[6-O-acetyl-3-O-[2,6-dideoxy-3-O-methyl-4-C-[1-(2-methyl-1-oxobutoxy)ethyl]-a-L-lyxo-hexopyranosyl]-b-D-allopyranosyl]-2-amino-5-hydroxy-3,6-dioxo-1-cyclohexene-1-carboxylic acid; 2-Amino-5-(3-O-(2,6-dideoxy-4-C-((1S)-1-hydroxyethyl)-3-O-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-allopyranosyl)-5-hydroxy-3,6-dioxo-1-cyclohexene-1-carboxylic acid, 4'-(3-(((2R)-2-acetamido-2-carboxyethyl)thio)-2-((dithiocarboxy)amino)butyrate), 6'-acetate, 4''-C-((2S)-2-methylbutyrate), S-ester with N-acetyl-L-cysteine. CAS No. 101411-70-5. Molecular formula: C44H64N4O23S3. Mole weight: 1113.18. | |
Our database is helping our users find suppliers everyday.
